Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $250M | $408M | -38.73% |
Cost of Revenue | $209M | $211M | -0.95% |
Operating Income | $-1.96B | $-2.63B | +25.56% |
Net Income | $-1.8B | $-2.45B | +26.81% |
EPS (Basic) | $-4.64 | $-6.41 | +27.61% |
EPS (Diluted) | $-4.64 | $-6.41 | +27.61% |
R&D Expense | $1.56B | $2.28B | -31.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $12.01B | $15.68B | -23.41% |
Current Assets | $6.17B | $9.66B | -36.12% |
Total Liabilities | $2.61B | $3.97B | -34.20% |
Current Liabilities | $1.57B | $2.36B | -33.47% |
Stockholders' Equity | $9.4B | $11.71B | -19.75% |
Cash & Equivalents | $1.28B | $2.48B | -48.39% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-1.96B | $-2.26B | +13.57% |
Investing Cash Flow | $1.29B | $1.77B | -26.77% |
Financing Cash Flow | $13M | $48M | -72.92% |
D&A | $94M | $75M | +25.33% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -782.8% | -644.4% | -138.44% |
Net Margin | -718.4% | — | — |
ROE | -19.1% | — | — |
ROA | -15.0% | — | — |
Current Ratio | $3.926 | — | — |
Debt to Equity | $0.278 | — | — |
Other companies in Biotechnology